PGY1 Pharmacy Residency (Acute Care)
Prisma Health Richland Hospital – University of South Carolina
July 2020 – June 2021
Taylor Gregory, PharmD
Originally from Chapin, South Carolina, Taylor Gregory received his doctorate in pharmacy at East Tennessee State University after earning his bachelor’s degree in biology at the University of South Carolina. He chose to pursue his residency at Prisma Health because of the welcoming environment, the variety of rotations offered, and the opportunity to collaborate with other healthcare professionals while serving a diverse patient population. Gregory’s professional interests include infectious diseases, critical care and emergency medicine. He plans to pursue a PGY2 residency after completing his PGY1 training. In his free time, he enjoys spending time with friends, playing golf and cheering on the Gamecocks.
- Major project: Comparing the Incidence of Hematoma Expansion after Desmopressin Administration in Patients with Spontaneous Intracerebral Hemorrhage on Antiplatelet Medications
- MUE: Evaluation of a low dose ketamine for pain management policy
Morgan Pizzuti, PharmD
Originally from Charleston, South Carolina, Morgan Pizzuti earned her Doctorate of Pharmacy from the University of South Carolina College of Pharmacy. She decided to pursue her PGY1 residency at Prisma Health because of the interactions she had with preceptors as a student, the variety of learning experiences offered, and the many opportunities to engage with learners. Professionally, she is interested in infectious diseases. Her spare time is spent hanging out with friends and family, cheering on the Gamecocks and enjoying the outdoors.
- Major Project: Validation of Local Pseudomonas aeruginosa Risk Factors in Patients with Community-Onset Bacterial Pneumonia
- MUE: Evaluation of non-formulary medication processes
Taylor Teshon, PharmD
Originally from Charlotte, North Carolina, Taylor Teshon received her Doctorate of Pharmacy from the University of North Carolina Eshelman School of Pharmacy. She chose to pursue her residency at Prisma Health because of the wide variety of clinical learning experiences, the supportive atmosphere created by the preceptors, and the opportunity to precept pharmacy students. Teshon’s professional interests include critical care and cardiology. In her free time, she enjoys baking, watching movies on Netflix, and playing with her cat, Pippin.
- Major project: A Comparison of Sodium Zirconium Cyclosilicate and Sodium Polystyrene Sulfonate in Adult, Hospitalized Patients with Hyperkalemia
- MUE: Evaluation of the prescription of nitroglycerin after acute myocardial infarction
Vivian Tsai, PharmD
Vivian Tsai received her Doctor of Pharmacy from the University of Pittsburgh School of Pharmacy. She chose to pursue her residency training at Prisma Health because of the variety of rotations offered and the availability of preceptors, offering her a supportive and challenging learning experience. Tsai’s professional interests include infectious diseases. In her free time, she enjoys playing the piano and watching movies.
- Major project: Predictive Factors for Treatment Success in Nontuberculosis Mycobacterial (NTM) Infections
- MUE: Cost effectiveness of levalbuterol versus albuterol in cardiovascular intensive care unit (CVICU) patients
Austin Williams, PharmD
Originally from Fountain Inn, South Carolina, Austin Williams earned his Doctor of Pharmacy from the University of South Carolina College of Pharmacy in Columbia. As a student, Austin was an intern in the Prisma Health Richland inpatient pharmacy. After completing many of his student rotations at Prisma Health Richland Hospital and seeing the diverse learning opportunities and clinical rotations firsthand, he chose to pursue his PGY1 residency with Prisma Health. Austin has an interest in the fields of critical care and infectious diseases. In his free time, he enjoys cheering on the USC Gamecocks, golfing with friends and fishing.
- Major project: Diagnostic Utility of Karius® Testing for Infectious Diseases
- MUE: Evaluation of P2Y12 inhibitor use in STEMI patients in an emergency department (ED) prior to primary percutaneous coronary intervention (PCI)